Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for induction and intubation in elderly patients with hypertension
ChiCTR2100042059Phase 4Recruiting
- Sponsor
- Foshan Fosun Chancheng Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam and propofol in hypertension (HTN) (2 arms), sponsored by Foshan Fosun Chancheng Hospital. Primary endpoint: Percentage of successful anesthesia induction. Started Oct 2020; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2100042059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042059.